Tavegyl 0.5 mg Syrup

Manufactured byNovartis India Ltd.
ContainsClemastine
Description

Tavegyl 0.5 mg Syrup is an antihistamine used to relieve the symptoms caused by allergic reactions like hay fever or urticaria. The symptoms may include sneezing, runny nose, itching eyes, etc.

Substitutes

List of substitutes for Tavegyl 0.5 mg Syrup

Side effects

Major & minor side effects for Tavegyl 0.5 mg Syrup

  • Dizziness and Drowsiness
  • Dry mouth
  • Headache
  • Nervousness
  • Difficulty in passing urine
  • Changes in vision
  • Rash
  • Itching
  • Difficulty in breathing
  • Nausea
  • Excitement

Uses of Tavegyl 0.5 mg Syrup

What is it prescribed for?

  • Allergic Rhinitis
  • Urticaria
  • Angioedema
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 15 to 60 minutes of administration of the dose.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 8 to 12 hours.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is it habit forming?
    No habit forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to clemastine or any other components present along with it.

Asthma

This medicine is not recommended for use in patients with asthma due to the increased risk of worsening of the patient's condition.

Neonates and premature infants

This medicine is not recommended for use in newborn children and premature infants due to the increased risk of serious side effects.

Monoamine oxidase inhibitors (MAO)

This medicine is not recommended for use in patients taking Monoamine oxidase inhibitors (MAO) such as isocarboxazid, phenelzine, etc. due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Anticholinergic effects

This medicine should be used with caution in patients with conditions like glaucoma, urinary retention, or urinary obstruction due to the increased risk of anticholinergic effects that can worsen the existing condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Missed Dose

If a dose of Tavegyl 0.5 mg Syrup is missed, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Topiramate

Ipratropium

Sodium oxybate

Disease interactions

Cardiovascular disease

This medicine should be used with caution in patients with a history of cardiovascular diseases due to the increased risk of severe side effects. These side effects may include an increased heart rate, arrhythmias, palpitations, hypotension, ECG changes, hypertension, and tachycardia. Close monitoring of heart function and vital signs is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition.

Renal Diseases

This medicine should be used with caution in patients with renal diseases due to the increased risk of severe adverse effects. Appropriate dose adjustments and close monitoring of kidney function may be required based on the clinical condition.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Appropriate dose adjustments and close monitoring of liver function may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Strictly follow all the instructions on the label and take Tavegyl 0.5 mg Syrup only as directed. Do not take more than the prescribed dose. It is advised that you should inform the doctor about all the medicines or herbal products that you are using and about all your medical conditions before taking this medicine. Use this medicine only for the prescribed purpose. Report any unusual symptoms to the doctor immediately. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Tavegyl 0.5 mg Syrup blocks the action of histamine, a natural substance responsible for allergic reactions.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antihistamines

Schedule

N/A

[Internet]. 2017 [cited 30 August 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/21054

Clemastine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 30 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00283

Clemastine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 30 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a682542.html

DailyMed - Clemastine Fumarate syrup [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f5dbf44-7cad-491f-ad5f-ad4bd06682a6

DailyMed - Clemastine Fumarate tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14aaadca-7d86-47e8-8483-6e05d456949d

Toxnet [Internet]. Toxnet.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~muAR6h:4
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error